(Q44557083)

4 December 2017

Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

4 December 2017

pancreaticoduodenectomy

0 references

1 reference

1 reference

1 reference

Minako Nagai

1

1 reference

4 December 2017

Masayuki Sho

2

1 reference

4 December 2017

Sohei Satoi

3

1 reference

4 December 2017

Hideyoshi Toyokawa

4

1 reference

4 December 2017

Takahiro Akahori

5

1 reference

4 December 2017

Hiroaki Yanagimoto

6

1 reference

4 December 2017

Tomohisa Yamamoto

7

1 reference

4 December 2017

Satoshi Hirooka

8

1 reference

4 December 2017

So Yamaki

9

1 reference

4 December 2017

Shoichi Kinoshita

10

1 reference

4 December 2017

Satoshi Nishiwada

11

1 reference

4 December 2017

Naoya Ikeda

12

1 reference

4 December 2017

A-Hon Kwon

13

1 reference

4 December 2017

Yoshiyuki Nakajima

14

1 reference

4 December 2017

20 June 2013

1 reference

Journal of Hepato-biliary-Pancreatic Sciences

4 December 2017

1 reference

4 December 2017

21

1 reference

4 December 2017

3

1 reference

4 December 2017

186-192

1 reference

Management and outcomes of haemorrhage after pancreatogastrostomy versus pancreatojejunostomy.

4 December 2017

1 reference

Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients

21 January 2018

1 reference

Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality

21 January 2018

1 reference

A prognostic score to predict major complications after pancreaticoduodenectomy

21 January 2018

1 reference

Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system

21 January 2018

1 reference

Development of hepatic steatosis after pancreatoduodenectomy.

21 January 2018

1 reference

Potential risk factors for nonalcoholic steatohepatitis related to pancreatic secretions following pancreaticoduodenectomy

21 January 2018

1 reference

Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy.

21 January 2018

1 reference

Effect of pancreaticoduodenectomy on the course of hepatic steatosis

21 January 2018

1 reference

A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery

21 January 2018

1 reference

Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial

21 January 2018

1 reference

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

21 January 2018

1 reference

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer.

21 January 2018

1 reference

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study

21 January 2018

1 reference

Obesity, diabetes mellitus, and liver fibrosis

21 January 2018

1 reference

Nonalcoholic fatty liver disease

21 January 2018

1 reference

Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JHBP.14

1 reference

4 December 2017

1 reference